Latest Breaking News On - Salarius pharmaceuticals - Page 16 : comparemela.com

10 Market-Moving Stocks to Watch Today - Insider Monkey

The indexes struggled to recover today from a strong sell-off the day before, following poor retail earnings that sparked fears about inflation’s overall impact.

Colin browneDavid arthurBath body works incSalarius pharmaceuticalsLucid group incDrug administrationCisco systems incModerna incSnow lake resources ltdArmour incMoving stocksBody works incLucid groupPresident patrik friskUnder armourInsider monkey

Salarius Pharmaceuticals, Inc (SLRX) Completes SP-3164 Related Meeting with FDA, Plans to Submit IND in 2023

Salarius Pharmaceuticals, Inc (SLRX) Completes SP-3164 Related Meeting with FDA, Plans to Submit IND in 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David arthurSalarius pharmaceuticals incSalarius pharmaceuticalsDrug administrationInvestigational new drug

Salarius Pharmaceuticals (NASDAQ:SLRX) Upgraded at Zacks Investment Research

Salarius Pharmaceuticals (NASDAQ:SLRX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Salarius Pharmaceuticals Inc. is a clinical-stage oncology company. It develops therapies for the treatment of cancers. The company’s lead candidate is Seclidemstat, which is […]

United statesSalarius pharmaceuticalsHightower advisorsZacks investment researchRenaissance technologiesSalarius pharmaceuticals company profile get ratingSalarius pharmaceuticals incPharma incCitadel advisorsMillennium managementGet ratingPharmaceuticals incFlex pharma incTower advisorsSigma advisersPharmaceuticals company profile

Salarius Pharmaceuticals : Announces $2 3 Million Registered Direct Offering - Form 8-K

Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced that it has entered into. | April 22, 2022

New yorkUnited statesJohanna bennettLisa sherTiberend strategic advisors incLadenburg thalmann co incExchange commissionSalarius pharmaceuticals incProspectus departmentLadenburg thalmann coSalarius pharmaceuticalsRegistered direct offeringLadenburg thalmannSecurities actSecurities litigation reform actStrategic advisors

Salarius Pharmaceuticals, Inc Announces $2 3 Million Registered Direct Offering

Salarius Pharmaceuticals, Inc Announces $2 3 Million Registered Direct Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJohanna bennettLisa sherTiberend strategic advisors incLadenburg thalmann co incExchange commissionSalarius pharmaceuticals incProspectus departmentLadenburg thalmann coSalarius pharmaceuticalsLadenburg thalmannSecurities actSecurities litigation reform actStrategic advisors